Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 25;54(8):1043-1048.
doi: 10.3724/abbs.2022096.

Gi-protein-coupled β 1-adrenergic receptor: re-understanding the selectivity of β 1-adrenergic receptor to G protein

Affiliations
Review

Gi-protein-coupled β 1-adrenergic receptor: re-understanding the selectivity of β 1-adrenergic receptor to G protein

Hao Chen et al. Acta Biochim Biophys Sin (Shanghai). .

Abstract

β 1-adrenergic receptor (β 1-AR), a member in the family of G-protein-coupled receptors, is a transmembrane receptor of great significance in the heart. Physiologically, catecholamines activate β 1-AR to initiate a positive chronotropic, inotropic, and dromotropic change. It is believed that β 1-AR couples to Gs protein and transmits the signal through second messenger cAMP. However, increasing research shows that β 1-AR can also bind with Gi protein in addition to Gs. When β 1-AR-Gi is biasedly activated, cardioprotective effects are introduced by the activated cGMP-protein kinase G (PKG) pathway and the transactivation of epidermal growth factor receptor (EGFR) pathway. The discovery of β 1-AR-Gi signaling makes us reconsider the selectivity of G protein with regard to β 1-AR, which also provides new ideas for the treatment of heart diseases. This review summarizes the discovery of β 1-AR-Gi pathway, including the evidence that supports β 1-AR's capability to couple Gi, details of the transduction process and functions of the β 1-AR-Gi signaling pathway.

Keywords: G protein switch; Gi protein; cardioprotective effect; signal transduction; β-adrenergic receptor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

None
Figure 1
Different signaling pathways, same cardioprotective effects EGFR-ERK pathway and NOS3-cGMP-PKG signaling can be activated by biased activation of β 1-AR-Gi pathway. Both signaling pathways play a role in cardiac protection.

Similar articles

Cited by

References

    1. Kahsai AW, Pani B, Lefkowitz RJ. GPCR signaling: conformational activation of arrestins. Cell Res. . 2018;28:783–784. doi: 10.1038/s41422-018-0067-x. - DOI - PMC - PubMed
    1. Baker AJ. Adrenergic signaling in heart failure: a balance of toxic and protective effects. Pflugers Arch. . 2014;466:1139–1150. doi: 10.1007/s00424-014-1491-5. - DOI - PubMed
    1. Lymperopoulos A, Rengo G, Koch WJ. Adrenergic nervous system in heart failure. Circ Res. . 2013;113:739–753. doi: 10.1161/CIRCRESAHA.113.300308. - DOI - PMC - PubMed
    1. Zhang L, Wuri J, An L, Liu X, Wu Y, Hu H, Wu R, et al. Metoprolol attenuates intracerebral hemorrhage-induced cardiac damage by suppression of sympathetic overactivity in mice. Auton Neurosci. . 2021;234:102832. doi: 10.1016/j.autneu.2021.102832. - DOI - PubMed
    1. Prins KW, Neill JM, Tyler JO, Eckman PM, Duval S. Effects of beta-blocker withdrawal in acute decompensated heart failure: a systematic review and meta-analysis. JACC Heart Fail. . 2015;3:647–653. doi: 10.1016/j.jchf.2015.03.008. - DOI - PMC - PubMed

MeSH terms